Owlet (OWLT) Stock: Buy, Sell, or Hold?
OWLT - Owlet, Inc.
$4.10
-0.05 (-1.20%)
▼
5d:
-0.24%
30d:
-19.13%
90d:
-21.61%
BUY
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 12, 2026
19d
Get Alerted When OWLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OWLT shows positive signals but monitor for confirmation. Market pricing in 30.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: OWLT shows positive signals but monitor for confirmation. Market pricing in 30.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.45
Based on -4.0% avg growth
INTRINSIC VALUE TODAY
$2.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OWLT is currently trading at $4.10, which is considered oversold relative to its 30-day fair value range of $4.35 to $5.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.9) compared to its historical average (55.8). Remarkably, the market is currently pricing in an annual earnings decline of 30.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OWLT is in a downtrend. The price is currently testing key support at $4.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OWLT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.00 (+213.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OWLT is in a downtrend. The price is currently testing key support at $4.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OWLT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.00 (+213.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.35 -
$5.11
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 213.3% below Wall St target ($13.00)
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$4.35 -
$5.11
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.52
(12.6%)
Support & Resistance Levels
Support Level
$4.03
Resistance Level
$4.73
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.86
Wall Street Target
$13.00
(+213.3%)
Revenue Growth (YoY)
29.9%
Profit Margin
-8.4%
Valuation Discount vs History
-30.4% cheaper
PE vs Historical
18.9 vs 55.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-30.4%
(market-implied from PE analysis)
1-Year Target
$3.74
(-10%)
2-Year Target
$3.36
(-19%)
3-Year Target
$3.03
(-27%)
3-Yr Target (if PE normalizes)
(PE: 19→56)
$8.95
(+116%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -12.0%)
$3.19
(+-23%)
Base:
(SPY PE: 18.9, Growth: -12.0%)
$3.03
(-27%)
Bear:
(PE: 16.0, Growth: -12.0%)
$2.57
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.9 to 55.8
Stabilization Target:
$12.28
(+195.8%)
PE Expansion Potential:
+195.8%
Share & Embed Analysis
Last updated: October 23, 2026 4:52 PM ET
Data refreshes hourly during market hours. Next update: 5:52 PM
Data refreshes hourly during market hours. Next update: 5:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OWLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
